Relationship between antiviral activity and host toxicity: comparison of the incorporation efficiencies of 2',3'-dideoxy-5-fluoro-3'-thiacytidine-triphosphate analogs by human immunodeficiency virus type 1 reverse transcriptase and human mitochondrial DNA polymerase. 2004

Joy Y Feng, and Eisuke Murakami, and Suzana M Zorca, and Allison A Johnson, and Kenneth A Johnson, and Raymond F Schinazi, and Phillip A Furman, and Karen S Anderson
Gilead Sciences, Durham, North Carolina 27707, USA.

Emtricitabine [(-)FTC; (-)-beta-L-2'-3'-dideoxy-5-fluoro-3'-thiacytidine] is an oxathiolane nucleoside analog recently approved by the Food and Drug Administration for the treatment of human immunodeficiency virus (HIV). Structurally, (-)FTC closely resembles lamivudine [(-)3TC] except that the former is 5-fluorinated on the cytosine ring. In HIV-1 reverse transcriptase (RT) enzymatic assays, the triphosphate of (-)FTC [(-)FTC-TP] was incorporated into both DNA-DNA and DNA-RNA primer-templates nearly 3- and 10-fold more efficiently than (-)3TC-TP. Animal studies and clinical trial studies have demonstrated a favorable safety profile for (-)FTC. However, a detailed study of the incorporation of (-)FTC-TP by human mitochondrial DNA polymerase gamma, a host enzyme associated with nucleoside toxicity, is required for complete understanding of the molecular mechanisms of inhibition and toxicity. We studied the incorporation of (-)FTC-TP and its enantiomer (+)FTC-TP into a DNA-DNA primer-template by recombinant human mitochondrial DNA polymerase in a pre-steady-state kinetic analysis. (-)FTC-TP was incorporated 2.9 x 10(5)-, 1.1 x 10(5)-, 1.6 x 10(3)-, 7.9 x 10(3)-, and 100-fold less efficiently than dCTP, ddCTP, (+)3TC-TP, (+)FTC-TP, and (-)3TC-TP, respectively. The rate of removal of (-)FTC-MP from the corresponding chain-terminated 24-mer DNA by polymerase gamma's 3'-->5' exonuclease activity was equal to the removal of (+)FTC-MP, 2-fold slower than the removal of (-)3TC-MP and (+)3TC-MP, and 4.6-fold slower than the excision of dCMP. These results demonstrate that there are clear differences between HIV-1 RT and polymerase gamma in terms of preferences for substrate structure.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D003845 Deoxycytosine Nucleotides Cytosine nucleotides which contain deoxyribose as the sugar moiety. Deoxycytidine Phosphates,Nucleotides, Deoxycytosine,Phosphates, Deoxycytidine
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004259 DNA-Directed DNA Polymerase DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. DNA Polymerase,DNA Polymerases,DNA-Dependent DNA Polymerases,DNA Polymerase N3,DNA Dependent DNA Polymerases,DNA Directed DNA Polymerase,DNA Polymerase, DNA-Directed,DNA Polymerases, DNA-Dependent,Polymerase N3, DNA,Polymerase, DNA,Polymerase, DNA-Directed DNA,Polymerases, DNA,Polymerases, DNA-Dependent DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074002 DNA Polymerase gamma A DNA-directed DNA polymerase that functions in the replication of MITOCHONDRIAL DNA. Mutations in the gene that encodes this enzyme (POLG) are associated with some forms of OPHTHALMOPLEGIA, CHRONIC EXTERNAL PROGRESSIVE. DNA Polymerase Subunit gamma-1,PolG-alpha,Mitochondrial DNA Polymerase,DNA Polymerase Subunit gamma 1,DNA Polymerase, Mitochondrial,PolG alpha,Polymerase gamma, DNA,Polymerase, Mitochondrial DNA
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

Joy Y Feng, and Eisuke Murakami, and Suzana M Zorca, and Allison A Johnson, and Kenneth A Johnson, and Raymond F Schinazi, and Phillip A Furman, and Karen S Anderson
May 1996, Molecular pharmacology,
Joy Y Feng, and Eisuke Murakami, and Suzana M Zorca, and Allison A Johnson, and Kenneth A Johnson, and Raymond F Schinazi, and Phillip A Furman, and Karen S Anderson
August 1996, Journal of virology,
Joy Y Feng, and Eisuke Murakami, and Suzana M Zorca, and Allison A Johnson, and Kenneth A Johnson, and Raymond F Schinazi, and Phillip A Furman, and Karen S Anderson
May 1998, Molecular pharmacology,
Joy Y Feng, and Eisuke Murakami, and Suzana M Zorca, and Allison A Johnson, and Kenneth A Johnson, and Raymond F Schinazi, and Phillip A Furman, and Karen S Anderson
October 1994, Antimicrobial agents and chemotherapy,
Joy Y Feng, and Eisuke Murakami, and Suzana M Zorca, and Allison A Johnson, and Kenneth A Johnson, and Raymond F Schinazi, and Phillip A Furman, and Karen S Anderson
August 1992, Antimicrobial agents and chemotherapy,
Joy Y Feng, and Eisuke Murakami, and Suzana M Zorca, and Allison A Johnson, and Kenneth A Johnson, and Raymond F Schinazi, and Phillip A Furman, and Karen S Anderson
February 1990, Molecular pharmacology,
Joy Y Feng, and Eisuke Murakami, and Suzana M Zorca, and Allison A Johnson, and Kenneth A Johnson, and Raymond F Schinazi, and Phillip A Furman, and Karen S Anderson
July 1994, Journal of medicinal chemistry,
Joy Y Feng, and Eisuke Murakami, and Suzana M Zorca, and Allison A Johnson, and Kenneth A Johnson, and Raymond F Schinazi, and Phillip A Furman, and Karen S Anderson
August 1999, Antimicrobial agents and chemotherapy,
Joy Y Feng, and Eisuke Murakami, and Suzana M Zorca, and Allison A Johnson, and Kenneth A Johnson, and Raymond F Schinazi, and Phillip A Furman, and Karen S Anderson
September 1995, Biochemical pharmacology,
Joy Y Feng, and Eisuke Murakami, and Suzana M Zorca, and Allison A Johnson, and Kenneth A Johnson, and Raymond F Schinazi, and Phillip A Furman, and Karen S Anderson
September 1990, European journal of biochemistry,
Copied contents to your clipboard!